The pharmacodynamic and clinical trial evidence for statin dose-Reference-Cited by-同舟云学术

The pharmacodynamic and clinical trial evidence for statin dose

Published:2018-04-16 Issue:6 Volume:84 Page:1128-1135
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Dimmitt Simon B.¹^ORCID,Stampfer Hans G.²^ORCID,Warren John B.³^ORCID

Affiliation:

1. Division of Internal Medicine, Faculty of Health and Medical Sciences; University of Western Australia; Suite 2, 62 Archibald St Willagee Western Australia 6156 Australia

2. Division of Psychiatry, Faculty of Health and Medical Sciences; University of Western Australia; Australia

3. Medicines Assessment Ltd; 196 Rotherhithe St London SE16 7RB UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13539/fullpdf

Reference55 articles.

1. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines;Stone;Circulation,2014

2. Cholesterol trials and mortality;Warren;Br J Clin Pharmacol,2016

3. Composite endpoints and the distortion of risk benefit analysis;Warren;Br J Clin Pharmacol,2017

4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Pedersen;Lancet,1994

5. Low-density lipoproteins and risk for coronary artery disease;Ballantyne;Am J Cardiol,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-course atherogenic blood lipid response to statin discontinuation in dyslipidemic adults;Nutrition, Metabolism and Cardiovascular Diseases;2024-10

2. Individualized Dose-Response to Statins Associated With Cardiovascular Disease Outcomes;JACC: Advances;2024-04

3. Bibliometric analysis of monoclonal antibodies for atherosclerosis;Human Vaccines & Immunotherapeutics;2023-10-31

4. PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines;Safety and Risk of Pharmacotherapy;2023-09-26

5. High-Dose Statins Increase Adverse Events and Do Not Improve Survival;Journal of the American College of Cardiology;2022-10